PRIMER DESIGN
LIVE

Serial Number

98723761

Owner

Primer Design Ltd.

Attorney

Ben Natter

Filing Date

Aug 29, 2024

Add to watchlist:

No watchlists yet
View on USPTO

PRIMER DESIGN Trademark

Serial Number: 98723761 • Registration: 8070884

PRIMER DESIGN is a trademark filed by Primer Design Ltd. on August 29, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Primer Design Ltd.

York House School Lane, Chandler's Ford
Eastleigh, England SO534DG , GB

Entity Type: 24

Trademark Details

Filing Date

August 29, 2024

Registration Date

December 16, 2025

Goods & Services

Chemical reagents for use in polymerase chain reactions for medical and veterinary purposes; chemicals reagents for medical and veterinary use, namely, chemical reagents for use in performing polymerase chain reactions for pathogen detection, detection of genetically modified organisms, species identification, and veterinary and medical disease detection; diagnostic preparations, namely, chemical preparations for use in the extraction of DNA and RNA from cells for medical and veterinary purposes; diagnostic preparations, namely, primers, reagents and other chemicals preparations for use in polymerase chain reactions for medical and veterinary purposes; chemicals reagents for use in RNA and DNA analysis for medical or veterinary purposes

Chemical preparations for scientific purposes, namely, chemical preparations for use in performing nucleic acid polymerase chain reactions for pathogen detection, water and food analysis, detection of genetically modified organisms, species identification, and biothreat detection; chemical preparations for use in polymerase chain reactions for research and analysis purposes, not in the medical or veterinary fields; chemicals preparations for scientific purposes, namely, for use in the extraction of DNA and RNA from cells; diagnostic preparations for scientific use, namely, primers, reagents and other chemicals preparations for use in polymerase chain reactions for laboratory purposes; chemicals reagents for use in RNA and DNA analysis other than for medical or veterinary purposes; kits comprised of reagents and assays for biotechnological and chemical research purposes

Custom manufacture of pharmaceuticals; information, advisory and consultation services in relation to the aforesaid; consulting services relating to pharmaceutical manufacturing; consulting services relating to commercial production of pharmaceuticals

Diagnostic apparatus for conducting polymerase chain reactions; diagnostic apparatus for conducting quantitative or real-time polymerase chain reactions; diagnostic apparatus namely, qPCR machines; diagnostic apparatus for pathogen detection, water and food analysis, detection of genetically modified organisms, species identification and bio-threat detection; diagnostic apparatus for use in extracting RNA and DNA; diagnostic apparatus for pathogen detection for use in agricultural environments; medical instruments, namely, sample containers, vials, dropping pipettes and stirrers in the nature of magnetic agitators used in the preparation of DNA and RNA samples for testing; medical instruments, namely, racks for holding medical sample tubes and vials during testing; replacement parts and fittings for all the aforesaid goods; accessories for the aforesaid goods, namely, dropping pipettes, medical sample tubes and vials; all the foregoing being for medical or veterinary purposes

Research laboratory analysis, product design and development, advisory services, consulting services, and product quality testing services, all in the fields of medicine, pharmaceuticals, veterinary science and food technology; research and development services relating to chemistry, biology and micro-biology; research and development services in the fields of diagnostic chemicals, compounds and devices, measuring apparatus for use in product research and development; product development of medical diagnostic test apparatus; testing and product development of biopharmaceuticals; laboratory research in the field of biopharmaceuticals; scientific laboratory services relating to detection and identification of micro-organisms; immunodiagnostic services in the nature of diagnostic services for others for scientific research purposes; chemical, biological and microbiological assay services, namely, providing chemical, biological and micro-biological assay testing and diagnostic services for others for scientific research purposes; custom biochemical assay development, testing, optimisation and validation; custom design and development of chemical reagents and biochemical assays; research support services in the nature of assay development and validation, product development, and report generation in relation to scientific research, all in the fields of virology, immunological, biological and biochemical research; scientific research services for others in the nature of preparation of technical documents and reports for medical and pharmaceutical products; information, advisory and consultation services in relation to the aforesaid; Consulting services relating to clinical evaluation and testing in the nature of clinical trials; Consulting services relating to chemical stability studies being pharmaceutical studies; Consulting services relating to development of chemical production methods

Laboratory apparatus for conducting polymerase chain reactions; laboratory apparatus for conducting quantitative or real-time polymerase chain reactions; medical laboratory research instruments for DNA analysis, namely, qPCR machines; laboratory apparatus for pathogen detection, water and food analysis, detection of genetically modified organisms, species identification and bio-threat detection; laboratory apparatus for use in extracting RNA and DNA; laboratory apparatus for pathogen detection for use in agricultural environments; laboratory instruments, namely, sample containers, vials, pipettes and stirrers in the nature of magnetic agitators used in the preparation of DNA and RNA samples for testing; laboratory instruments, namely, racks for holding sample pipettes and vials during testing; replacement parts and fittings for all the aforesaid goods; accessories for the aforesaid goods, namely, petri dishes, pipettes and test tubes; all the foregoing being for laboratory and research purposes

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 16, 2025 NRCS
REGISTERED-SUPPLEMENTAL REGISTER
Dec 16, 2025 R.SR
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Nov 14, 2025 CNTA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 4, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 4, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 4, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 11, 2025 GNFN
FINAL REFUSAL E-MAILED
Aug 11, 2025 GNFR
FINAL REFUSAL WRITTEN
Aug 11, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 21, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 21, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 21, 2025 TROA
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Jul 2, 2025 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Jul 2, 2025 GEAP
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Jul 2, 2025 EPEN
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Jul 2, 2025 CPEA
USE AMENDMENT ACCEPTED
Jul 1, 2025 IUAA
AMENDMENT TO USE PROCESSING COMPLETE
Jun 17, 2025 AUPC
USE AMENDMENT FILED
Jun 17, 2025 IUAF
TEAS AMENDMENT OF USE RECEIVED
Jun 17, 2025 EAAU
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 27, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 27, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 27, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 25, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 25, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 25, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 18, 2025 GNRN
NON-FINAL ACTION E-MAILED
Mar 18, 2025 GNRT
NON-FINAL ACTION WRITTEN
Mar 18, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 5, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 29, 2024 NWOS
NEW APPLICATION ENTERED
Aug 29, 2024 NWAP